Patient Square Capital LP Diversified Active

CIK: 0001819257 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 11, 2025

Total Value ($000): $277,388 (100.0% shares, 0.0% debt)

Holdings (19)

ROIV ROIVANT SCIENCES LTD. 50.7%

Value ($000) $140,650 Shares 12,480,000 Est. Cost $7.21 Unrealized +50.3%

INSM INSMED INC 13.0%

Value ($000) $36,110 Shares 358,800 Est. Cost $73.51 Unrealized +4.0%

ARGX ARGENX SE - ADR 5.8%

Value ($000) $15,985 Shares 29,000 Est. Cost $551.22 Unrealized —

EYPT EYEPOINT PHARMACEUTICALS, INC. 4.6%

Value ($000) $12,730 Shares 1,352,837 Est. Cost $8.71 Unrealized -20.7%

LQDA LIQUIDIA CORPORATION 4.6%

Value ($000) $12,709 Shares 1,020,000 Est. Cost $13.90 Unrealized +6.5%

OCUL OCULAR THERAPEUTIX, INC. 2.7%

Value ($000) $7,588 Shares 817,699 Est. Cost $8.36 Unrealized -6.4%

CGEM CULLINAN THERAPEUTICS, INC. 2.4%

Value ($000) $6,543 Shares 868,897 Est. Cost $17.53 Unrealized -54.2%

KYMR KYMERA THERAPEUTICS, INC. 2.2%

Value ($000) $6,110 Shares 140,000 Est. Cost $36.45 Unrealized -5.5%

MIRM MIRUM PHARMACEUTICALS, INC. 2.1%

Value ($000) $5,774 Shares 113,462 Est. Cost $44.09 Unrealized +1.0%

SRRK SCHOLAR ROCK HOLDING CORPORATION 2.0%

Value ($000) $5,455 Shares 154,000 Est. Cost $37.24 Unrealized -15.7%

ELVN ENLIVEN THERAPEUTICS, INC. 1.8%

Value ($000) $4,932 Shares 245,838 Est. Cost $24.42 Unrealized -22.5%

NRIX NURIX THERAPEUTICS, INC. 1.7%

Value ($000) $4,696 Shares 412,296 Est. Cost $22.73 Unrealized -52.4%

AGIO AGIOS PHARMACEUTICALS, INC. 1.7%

Value ($000) $4,647 Shares 139,732 Est. Cost $45.20 Unrealized -32.9%

PHVS PHARVARIS N. V. 1.5%

Value ($000) $4,299 Shares 244,283 Est. Cost $18.06 Unrealized -10.8%

IRON DISC MEDICINE, INC. 1.4%

Value ($000) $3,919 Shares 74,000 Est. Cost $57.12 Unrealized -17.8%

ALLO ALLOGENE THERAPEUTICS, INC. 1.1%

Value ($000) $2,978 Shares 2,635,000 Est. Cost $2.16 Unrealized -38.4%

GERN GERON CORP 0.4%

Value ($000) $1,010 Shares 716,000 Est. Cost $1.42 Unrealized 0.0%

— CIDARA THERAPEUTICS INC 0.3%

Value ($000) $731 Shares 15,000 Est. Cost $48.71 Unrealized —

VYNE VYNE THERAPEUTICS INC. 0.2%

Value ($000) $523 Shares 317,033 Est. Cost $2.24 Unrealized -42.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ROIV	ROIVANT SCIENCES LTD.	12,480,000	$140,650	50.7%	$7.21	+50.3%	SHS	G76279101
INSM	INSMED INC	358,800	$36,110	13.0%	$73.51	+4.0%	COM PAR $.01	457669307
ARGX	ARGENX SE - ADR	29,000	$15,985	5.8%	$551.22	—	SPONSORED ADR	04016X101
EYPT	EYEPOINT PHARMACEUTICALS, INC.	1,352,837	$12,730	4.6%	$8.71	-20.7%	COM NEW	30233G209
LQDA	LIQUIDIA CORPORATION	1,020,000	$12,709	4.6%	$13.90	+6.5%	COM NEW	53635D202
OCUL	OCULAR THERAPEUTIX, INC.	817,699	$7,588	2.7%	$8.36	-6.4%	COM	67576A100
CGEM	CULLINAN THERAPEUTICS, INC.	868,897	$6,543	2.4%	$17.53	-54.2%	COM	230031106
KYMR	KYMERA THERAPEUTICS, INC.	140,000	$6,110	2.2%	$36.45	-5.5%	COM	501575104
MIRM	MIRUM PHARMACEUTICALS, INC.	113,462	$5,774	2.1%	$44.09	+1.0%	COM	604749101
SRRK	SCHOLAR ROCK HOLDING CORPORATION	154,000	$5,455	2.0%	$37.24	-15.7%	COM	80706P103
ELVN	ENLIVEN THERAPEUTICS, INC.	245,838	$4,932	1.8%	$24.42	-22.5%	COM	29337E102
NRIX	NURIX THERAPEUTICS, INC.	412,296	$4,696	1.7%	$22.73	-52.4%	COM	67080M103
AGIO	AGIOS PHARMACEUTICALS, INC.	139,732	$4,647	1.7%	$45.20	-32.9%	COM	00847X104
PHVS	PHARVARIS N. V.	244,283	$4,299	1.5%	$18.06	-10.8%	COM	N69605108
IRON	DISC MEDICINE, INC.	74,000	$3,919	1.4%	$57.12	-17.8%	COM	254604101
ALLO	ALLOGENE THERAPEUTICS, INC.	2,635,000	$2,978	1.1%	$2.16	-38.4%	COM	019770106
GERN	GERON CORP	716,000	$1,010	0.4%	$1.42	0.0%	COM	374163103
—	CIDARA THERAPEUTICS INC	15,000	$731	0.3%	$48.71	—	COM NEW	171757206
VYNE	VYNE THERAPEUTICS INC.	317,033	$523	0.2%	$2.24	-42.0%	COM	92941V308